AI Reasoning Model Helps Identify Leads for Rare Disease Diagnoses
A study reports that an OpenAI reasoning model improved rare disease diagnostic yield by 4.8% in previously unsolved cases, offering new leads after specialist analysis.
Read MorePosted by CLP Edit Staff | Jun 19, 2026 | Analytical Software Systems, Molecular Diagnostics |
A study reports that an OpenAI reasoning model improved rare disease diagnostic yield by 4.8% in previously unsolved cases, offering new leads after specialist analysis.
Read MorePosted by CLP Edit Staff | Jun 18, 2026 | Compliance |
The settlement resolves claims that Advanced Pathology Solutions provided illegal incentives to gastroenterology practices and performed unnecessary medical testing.
Read MorePosted by CLP Edit Staff | Jun 18, 2026 | Molecular Diagnostic Analyzers, Molecular Diagnostics |
A study reports that long-read genome sequencing can replace up to 15 separate tests and improve diagnostic yield for rare genetic disorders, according to researchers in the Netherlands.
Read MorePosted by CLP Edit Staff | Jun 12, 2026 | Prostate |
The test combines genomic risk assessment and digital pathology analysis to help clinicians tailor monitoring strategies.
Read MorePosted by CLP Edit Staff | Jun 12, 2026 | Anatomic Pathology, Cancer, Diagnostic Technologies |
The companion diagnostic evaluates mismatch repair deficiency, a predictive biomarker used to identify patients who may respond to PD-1-targeted therapies.
Read More